139 related articles for article (PubMed ID: 8355216)
1. DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities.
Cohen ML; Johnson MP; Schenck KW; Susemichel A; Wainscott DB; Robertson DW; Nelson DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):943-9. PubMed ID: 8355216
[TBL] [Abstract][Full Text] [Related]
2. Regulation of 5-hydroxytryptamine2 (5-HT2) receptor expression in cultured rat aortic smooth muscle cells by SR 46349B, a selective 5-HT2 receptor antagonist.
Rinaldi-Carmona M; Prabonnaud V; Bouaboula M; Poinot-Chazel C; Casellas P; Le Fur G; Herbert JM
J Biol Chem; 1994 Jan; 269(1):396-401. PubMed ID: 8276825
[TBL] [Abstract][Full Text] [Related]
3. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation.
Akiyoshi J; Hough C; Chuang DM
Mol Pharmacol; 1993 Mar; 43(3):349-55. PubMed ID: 8383800
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1992 Jun; 261(3):856-62. PubMed ID: 1602389
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
Killam AL; Nikam SS; Lambert GM; Martin AR; Nelson DL
J Pharmacol Exp Ther; 1990 Mar; 252(3):1083-9. PubMed ID: 2319460
[TBL] [Abstract][Full Text] [Related]
7. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
Teitler M; Leonhardt S; Weisberg EL; Hoffman BJ
Mol Pharmacol; 1990 Nov; 38(5):594-8. PubMed ID: 2233696
[TBL] [Abstract][Full Text] [Related]
8. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
[TBL] [Abstract][Full Text] [Related]
9. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of rat peripheral 5-HT(2A) and 5-HT(2B) receptor systems: influence of drug treatment.
Enguix MJ; Sánchez L; Villazón M; Brea J; Tristán H; Caruncho HJ; Cadavid MI; Loza MI
Naunyn Schmiedebergs Arch Pharmacol; 2003 Aug; 368(2):79-90. PubMed ID: 12861437
[TBL] [Abstract][Full Text] [Related]
11. Role of 5-HT2 receptors in serotonin-induced contractions of nonvascular smooth muscle.
Cohen ML; Schenck KW; Colbert W; Wittenauer L
J Pharmacol Exp Ther; 1985 Mar; 232(3):770-4. PubMed ID: 3973826
[TBL] [Abstract][Full Text] [Related]
12. Attenuated 5-hydroxytryptamine receptor-mediated responses in aortae from streptozotocin-induced diabetic rats.
James GM; Hodgson WC; Davis EA; Haynes JM
Br J Pharmacol; 1994 Jan; 111(1):370-6. PubMed ID: 8012721
[TBL] [Abstract][Full Text] [Related]
13. Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.
Cheer JF; Cadogan AK; Marsden CA; Fone KC; Kendall DA
Neuropharmacology; 1999 Apr; 38(4):533-41. PubMed ID: 10221757
[TBL] [Abstract][Full Text] [Related]
14. Serotonin-dependent collagenase induction in rat myometrial smooth muscle cells: mediation by the 5-HT2 receptor.
Rydelek-Fitzgerald L; Wilcox BD; Teitler M; Jeffrey JJ
Mol Cell Endocrinol; 1993 Feb; 91(1-2):67-74. PubMed ID: 8472855
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological characterization of 5-hydroxytryptamine2 receptors in the rat medial prefrontal cortex.
Ashby CR; Jiang LH; Kasser RJ; Wang RY
J Pharmacol Exp Ther; 1990 Jan; 252(1):171-8. PubMed ID: 2137174
[TBL] [Abstract][Full Text] [Related]
16. Effect of endothelium on diabetes-induced changes in constrictor responses mediated by 5-hydroxytryptamine in rat aorta.
Sikorski BW; James GM; Glance SD; Hodgson WC; King RG
J Cardiovasc Pharmacol; 1993 Sep; 22(3):423-30. PubMed ID: 7504133
[TBL] [Abstract][Full Text] [Related]
17. Serotonin receptor activation of phosphoinositide turnover in uterine, fundal, vascular, and tracheal smooth muscle.
Cohen ML; Wittenauer LA
J Cardiovasc Pharmacol; 1987 Aug; 10(2):176-81. PubMed ID: 2441168
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the contractile serotonergic receptor in guinea pig trachea with agonists and antagonists.
Watts SW; Cohen ML
J Pharmacol Exp Ther; 1992 Mar; 260(3):1101-6. PubMed ID: 1312158
[TBL] [Abstract][Full Text] [Related]
19. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
20. Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.
Welch JE; Saphier D
J Pharmacol Exp Ther; 1994 Sep; 270(3):918-28. PubMed ID: 7932204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
